Séroépidémiologie de la rubéole, de la varicelle et des infections par le cytomégalovirus et le parvovirus B19 chez les femmes enceintes dans la région de Sousse, Tunisie

Alanen A, Kahala K, Vahlberg T, et al (2005) Seroprevalence, incidence of prenatal infections and reliability of maternal history of varicella zoster virus, cytomegalovirus, herpes simplex virus and parvovirus B19 infection in South-Western Finland. BJOG 112(1):50–56

Alfonsi V, Montomoli E, Manini I, et al (2007) Susceptibility to varicella in childbearing age women, Central Italy: is there a need for vaccinating this population group? Vaccine 25(32):6086–6088 [Epub 2007 June 4]

Ashrafunnessa, Khatun S, Islam MN, Chowdhury S (2000) Seroprevalence of rubella antibodies among antenatal population attending a tertiary level hospital in Dhaka City. Bangladesh Med Res Counc Bull 26(3):75–81

Barah F, Chehada AG (2010) Prevalence of rubella IgG antibodies among Syrian females of childbearing age. Saudi Med J 31(1):78–81

Caidi H, Bloom S, Azilmaat M, et al (2009) Rubella seroprevalence among women aged 15-39 years in Morocco. East Mediterr Health J 15(3):526–531

Clemens SA, Azevedo T, Fonseca JC, et al (1999) Seroepidemiology of varicella in Brazil: results of a prospective cross-sectional study. J Pediatr (Rio J) 75(6):433–441

el-Nawawy A, Soliman AT, el Azzouni O, et al (1996) Maternal and neonatal prevalence of toxoplasma and cytomegalovirus (CMV) antibodies and hepatitis-B antigens in an Egyptian rural area. J Trop Pediatr 42(3):154–157

Elnifro E, Nisha AK, Almabsoot M, et al (2009) Seroprevalence of parvovirus B19 among pregnant women in Tripoli, Libya. J Infect Dev Ctries 3(3):218–220

Faye-Kette YH, Sylla-Koko DJ, Akoua-Koffi GC, et al (1993) Séroprévalence de la rubéole chez 461 femmes enceintes à Abidjan (Côte-d’Ivoire). Bull Soc Pathol Exot 86(3):185–187

Fillet AM, Lebon P (1999) Virus de la varicelle et du zona. In: Denis F (ed) Les virus transmissibles de la mère à l’enfant. John Libbey Eurotext, Paris, pp 240–251

Fowler KB, Stagno S, Pass RF, et al (1992) The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 326(10):663–667

Gargouri J, Elleuch H, Karray H, et al (2000) Prevalence of anti-CMV antibodies in blood donors in the Sfax region (value in blood transfusion). Tunis Med 78(8–9): 512–517

Ghebrekidan H, Rudén U, Cox S, et al (1999) Prevalence of herpes simplex virus types 1 and 2, cytomegalovirus, and varicella-zoster virus infections in Eritrea. J Clin Virol 12(1):53–64

Gratacap-Cavallier B, Morand P, Dutertre N, et al (1998) Infection à cytomégalovirus chez la femme enceinte. Étude séroépidémiologique prospective chez 1 018 femmes en Isère. J Gynecol Obstet Biol Reprod (Paris) 27(2):161–166

Haddad-Boubaker S, Ben Yahia A, Bahri O, Triki H (2004) Étude de l’infection par le virus de la rubéole chez l’enfant et l’adolescent en Tunisie. Pathol Biol (Paris) 52:11–15

Khemiri B, Mahjoub S, Hmid RB, et al (1997) La séroprévalence de la toxoplasmose et de la rubéole parmi une population de femmes enceintes consultant au CMNRT. Tunis Med 75:788–793

Kurugol Z, Koturoglu G, Aksit S, Ozacar T (2007) Varicella seroprevalence in Turkish population in Cyprus. Acta Paediatr 96(6):861–863 [Epub 2007 April 27]

Laub R, Strengers P (2002) Parvoviruses and blood products. Pathol Biol (Paris) 50(5):339–348

Letaïef M, Vanham G, Boukef K, et al (1997) Higher prevalence of parvovirus B19 in Belgian as compared to Tunisian blood donors: differential implications for prevention of transfusional transmission. Transfus Sci 18(4):523–530

Lin KH, You SL, Chen CJ, et al (1999) Seroepidemiology of human parvovirus B19 in Taiwan. J Med Virol 57(2):169–173

Lolekha S, Tanthiphabha W, Sornchai P, et al (2001) Effect of climatic factors and population density on varicella zoster virus epidemiology within a tropical country. Am J Trop Med Hyg 64(3–4):131–136

Marcelin AG, Soulié JC, Lefrère JJ, et al (1999) Parvovirus B19. In: Denis F (ed) Les virus transmissibles de la mère à l’enfant. John Libbey Eurotext, Paris, pp 289–304

Markenson GR, Yancey MK (1998) Parvovirus B19 infections in pregnancy. Semin Perinatol 22:309–317

Marshall GS, Stout GG (2005) Cytomegalovirus seroprevalence among women of childbearing age during a 10-year period. Am J Perinatol 22(7):371–376

Morinet F, Pallier C, Pillet S (2003) Parvoviridae. In: Huraux JM, Nicolas JC, Agut H, Peigue-Lafeuille H, Estem (eds) Traité de virologie médicale, Paris, pp 283–289

Nabli B (1970) Seroepidemiology of rubella in Tunisia. Bull World Health Organ 42(6):891–896

Nardone A, Tischer A, Andrews N, et al (2008) Comparison of rubella seroepidemiology in 17 countries: progress towards international disease control targets. Bull World Health Organ 86(2):118–125

Palihawadana P, Wickremasinghe AR, Perera J (2003) Seroprevalence of rubella antibodies among pregnant females in Sri Lanka. Southeast Asian. J Trop Med Public Health 34(2):398–404

Picone O, Grangeot-Keros L (2005) Rubéole et grossesse. EMC Gynecol Obstet 2(4):343–353

Plans P, Costa J, Espuñes J, et al (2007) Prevalence of varicellazoster antibodies in pregnant women in Catalonia (Spain). Rationale for varicella vaccination of women of childbearing age. BJOG 114(9):1122–1127

Ranger-Rogez S, Venot C, Aubart Y, et al (1999) Cytomégalovirus. In: Denis F (ed) Les virus transmissibles de la mère à l’enfant. John Libbey Eurotext, Paris, pp 214–239

Saadatian-Elahi M, Mekki Y, Del Signore C, et al (2007) Seroprevalence of varicella antibodies among pregnant women in Lyon-France. Eur J Epidemiol 22(6):405–409 [Epub 2007 May 30]

Stroffolini T, Ngatchu T, Chiaramonte M, et al (1993) Prevalence of cytomegalovirus seropositivity in an urban childhood population in Cameroon. New Microbiol 16(1):83–85

Tapia-Conyer R, Sepúlveda J, Salvatierra B, et al (1992) Determining factors of rubella in the 10 to 14 year-old population in Mexico. Salud Publica Mex 34(2):211–221

Trevisan A, Frasson C, Morandin M, et al (2007) Immunity against infectious diseases: predictive value of self-reported history of vaccination and disease. Infect Control Hosp Epidemiol 28(5):564–569 [Epub 2007 April 12]

Valeur-Jensen AK, Pedersen CB, Westergaard T, et al (1999) Risk factors for parvovirus B19 infection in pregnancy. JAMA 281(12):1099–1105

Wang IJ, Hwang KC, Tsai YH, et al (2006) Rubella seroprevalence among young women Taipei county after routine measles, mumps and rubella immunization program. Acta Paediatr Taiwan 47(1):14–17

Ziyaeyan M, Pourabbas B, Alborzi A, et al (2007) Prevalence of antibody to human parvovirus B19 in preschool age/young adult individuals in Shiraz, Iran. Pak J Biol Sci 10(10):1763–1765